|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
27 June 2016 |
|
Main ID: |
NCT02804360 |
|
Date of registration:
|
18/05/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study
|
|
Scientific title:
|
Dexamethasone in Retinitis Pigmentosa Cystoid Macular Edema |
|
Date of first enrolment:
|
January 2015 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Enrolling by invitation |
|
URL:
|
https://clinicaltrials.gov/show/NCT02804360 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Contacts
|
|
Name:
|
Ahmad Mansour, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
RHUH |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria: Retinitis pigmentosa with cystoid macular edema -
Exclusion Criteria: infection, inability to consent, cataract, glaucoma, end-stage
retinitis pigmentosa
Age minimum:
16 Years
Age maximum:
90 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Retinitis Pigmentosa
|
|
Cystoid Macular Edema
|
|
Intervention(s)
|
|
Device: dexamethasone injection
|
|
Primary Outcome(s)
|
|
visual gain measured as Snellen visual acuity
[Time Frame: 4 months]
|
|
Secondary Outcome(s)
|
|
resolution of macular edema by OCT
[Time Frame: 4 months]
|
|
Secondary ID(s)
|
|
INV-2016-267
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|